FDA Import Refusal 799-4874980-4/1/2 — Glaxo India

Glaxo India — FEI 3000146207

The FDA refused shipment 799-4874980-4/1/2 from Glaxo India (India) on April 22, 2016. The refused product falls under Drugs and Biologics — ACETAMINOPHEN (ANALGESIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
April 22, 2016
Country
India
Product Category
Drugs and Biologics
Product Code
60LAA01 ACETAMINOPHEN (ANALGESIC)
Charges
75